Study to Evaluate the Efficacy and Safety of BGB-11417 in Participants With Waldenstr öm's Macroglobulinemia
Conditions: Waldenstrom Macroglobulinemia; Waldenstrom's Macroglobulinemia Recurrent; Waldenstrom's Macroglobulinemia Refractory Intervention: Drug: BGB-11417 Sponsor: BeiGene Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials